How can healthcare executives navigate the growing antitrust scrutiny of healthcare mergers, and what are some of the key issues facing executives in the current regulatory environment? In this conversation with The Chartis Group, McDermott Partner Katharine O’Connor discusses the legal considerations for healthcare executives seeking to navigate mergers.
Growing Antitrust Scrutiny of Healthcare Mergers: What Healthcare Executives Need to Know
By Katharine O’Connor on October 5, 2022
Posted In Health and Welfare Plans
Katharine O’ConnorKatharine (Kate) O’Connor focuses her practice on complex antitrust litigation, antitrust investigations brought by the US antitrust regulators and state attorneys general, and counseling clients on antitrust compliance questions. Kate also regularly represents clients before the antitrust regulators related to mergers and acquisitions. Kate has experience representing clients in a wide array of industries, including healthcare, manufacturing, food and finance. Kate is a member of the firm’s antitrust and competition practice, which Global Competition Review has designated a “Global Elite” and “Illinois Elite” practice. She has been recognized by Global Competition Review, Benchmark Litigation, Legal 500 US and Super Lawyers as excelling in the field of antitrust. Read Katharine O’Connor's full bio.
Related Posts
- Bipartisan Health Bills Pick Up Steam, but Contentious Debt Ceiling Negotiations Continue
- HIPAA Challenges: State AGs Crack Down on Data Privacy
- Healthcare Predictions for 2023: Hard Choices and Working Smarter
- The Inflation Reduction Act of 2022: Healthcare Provisions
- HHS Issues Proposed Rule Under Section 1557 of the Affordable Care Act: Nondiscrimination in Health Programs and Activities
BLOG EDITORS
STAY CONNECTED
TOPICS
ARCHIVES
RECENT POSTS
- Code § 4980D and Violations of the NQTL Analysis Requirement Under the Proposed MHPAEA Regulations
- Webinar Replay: SECURE 2.0 and the Impacts of Employer Matching for Student Loan Payments
- A Look into House Efforts on Hospital and Health Plan Price Transparency
- Texas District Court Overturns Portions of the IDR Process
- The “Meaningful Benefit” Requirement for NQTLs Under the Proposed MHPAEA Regulations
